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Nasser Nassiri Koopaei1 and Mohammad Abdollahi2,3,4*Erratum
After publication of this article [1], the authors clarify
that Nasser Nassiri Koopaei was affiliated to “Faculty of
Pharmacy and Pharmaceutical Sciences Research Center,
Tehran University of Medical Sciences, Tehran, Iran” at
the time the research was carried out.
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